CYPH
Cypherpunk Technologies Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.42
+6.61%Forward multiples
Based on analyst estimates
- P/E forward
- 30.25x
- P/E 2026E
- —
- P/E 2027E
- 19.79x
- P/E 2028E
- 12.50x
- P/S forward
- 4.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.10x
- PEG TTM
- —
- Price / book
- 1.87x
- Price / sales
- —
- Price / cash flow
- -8.98x
Enterprise value
- Enterprise value
- $253.2M
- EV / sales
- —
- EV / EBITDA
- -5.65x
- EV / EBIT
- -14.24x
- Market cap
- $260.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026